A cancer-focused drug discoverer and developer emerged from stealth mode by disclosing today that it has raised $40 million in Series A and Series B financings.
http://www.genengnews.com/gen-news-highlights/cancer-focused-vivace-emerges-with-40m-in-financing/81254586
Your email address will not be published. Required fields are marked *
Comment
Name *
Email *
Website
Leave a Reply